Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 2/20 | 0.56 |
| ▸ | NPY1R | P25929 | 1/20 | 0.54 |
| ▸ | NPY2R | P49146 | 1/20 | 0.54 |
| ▸ | NPY4R | P50391 | 1/20 | 0.54 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.54 |
| ▸ | CXCL8 | P10145 | 7/20 | 0.54 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.54 |
| ▸ | GLP1R | P43220 | 6/20 | 0.52 |
| ▸ | GIPR | P48546 | 6/20 | 0.52 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29611486 | 1.00 | KEAP1 (0.56) | KEAP1NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30576993 | 0.88 | CXCR4 (0.61) | KEAP1NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30690100 | 0.87 | CXCL8 (0.56) | CXCL8CXCR4GLP1R | |
| SCHEMBL30906406 | 0.86 | NPY1R (0.56) | KEAP1NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30262141 | 0.85 | CXCL8 (0.56) | KEAP1CXCL8 | |
| SCHEMBL31247321 | 0.84 | CAPN1 (0.58) | CXCL8CXCR4 | |
| SCHEMBL31182771 | 0.84 | CXCR4 (0.62) | KEAP1NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30906519 | 0.84 | NPY1R (0.54) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL31073513 | 0.83 | CXCR4 (0.59) | NPY1RNPY2RNPY4RNPY5RCXCL8 | |
| SCHEMBL30690108 | 0.83 | CAPN1 (0.59) | CXCL8CXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114207112-A | Method for culturing hair papilla cells | 花王株式会社 | 2022-03-18 | — | — | CN | disclosed |